News

Video

The future of Glaucoma 360: Residents and retina

Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will include retina discussions.

The continuation of this interview with Andrew Iwach, MD, a co-founder of the Glaucoma 360 conference encourages residents to attend the meeting as the event is a valuable learning experience as they develop their understanding of glaucoma and can stand at the forefront of innovation in this field or research and development. The meeting serves as both an educational platform and a fundraising event for a non-profit organization.

Iwach emphasizes the importance of user-friendly and practical approaches in the scientific community. They note that the typical process from idea to peer-reviewed publication can take 3-5 years, which the Glaucoma 360 event aims to address by being ahead of the curve. He also shares his personal experience of consistently learning new things by attending the annual meeting over the past 28 years.

Another key aspect of the event is the intersection between glaucoma and retina. For the past 10 years, the meeting has included a lecture by retinal specialists, and in 2026 the organizers will be adding a half-day program specifically focused on retina. This new "Glaucoma 360 Plus" program will be led by retina specialists J. Michael Jumper, MD and Gaurav K. Shah, MD, FASRS.

The website for the event is currently open for registration, and Iwach encourages early registration for the 2026 CME programs. The ongoing commitment to this annual event demonstrates its importance as a platform for learning, collaboration, and advancing the field of glaucoma. Overall, the interview highlights the Glaucoma 360 event as a unique and valuable opportunity for residents, fellows, and clinicians to engage with the latest developments, research, and best practices in glaucoma and related specialties.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.